For Novartis, M&A is both a disease and cure
The Swiss firm's market value fell over $30 bln after a drug acquired in a recent takeover disappointed, prompting calls for a board shake-up. But expiring patents in coming years will force CEO Vas Narasimhan to do deals. That may be harder if he is distracted by investor anger.
Read in depth: Business
Volkswagen reports €5.8 billion third-quarter loss as Porsche charge and China slump weigh
The German carmaker's July-to-September loss widened sharply from a year earlier, with a large Porsche writedown and falling deliveries in China adding to pressure on its results.
World Bank forecasts 23% commodity price rise as energy and shipping shocks mount
The bank projects higher energy, metals and food prices in 2026, with further risks from conflict, disrupted grain shipments and El Niño.
Sources and context
ReutersSource headline and summary supplied via NewsData.io. First collected by NewsJaws on 2026-09-12. This is an automated news brief, not original NewsJaws reporting. Dates reflect the source publication. Feed delays may apply.